Clinical Trial Results
What adverse reactions did participants have?
The most common adverse reaction was headache.
The table below shows the adverse reactions that happened during this study.
Adverse reactions during this study
100 μg of 600 μg of
AZD8871 AZD8871 Placebo
(Out of 34 (Out of 39 (Out of 36
participants) participants) participants)
Headache 5.9% (2) 2.6% (1) 2.8% (1)
Sudden need to urinate 2.9% (1) 0.0% (0) 0.0% (0)
Worsening of COPD 0.0% (0) 2.6% (1) 0.0% (0)
How has this study helped patients and
researchers?
The results presented here are from a single study. These results helped
researchers learn more about AZD8871, if it helps patients with COPD, how it
acts in the body, and if it is safe to take.
Researchers look at the results of many studies to decide which treatments
work best and are safest. Other studies may provide new information or different
results. Always talk to a doctor before making any changes in treatment.
Further clinical studies with AZD8871 are planned.
7